PubMed

Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration.

Jonas JB, Kreissig I, Degenring RF.

Br J Ophthalmol. 2004 Dec;88(12):1557-62.PMID: 15548812 [PubMed - indexed for MEDLINE]Related articlesFree article

Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.

Jonas JB, Spandau UH, Harder B, Vossmerbaeumer U, Kamppeter BA.

Am J Ophthalmol. 2005 Jun;139(6):1073-9.PMID: 15953439 [PubMed - indexed for MEDLINE]Related articles

Visual acuity change after intravitreal triamcinolone in various types of exudative age-related macular degeneration.

Jonas JB, Strueven V, Kamppeter BA, Harder B, Spandau UH, Schlichtenbrede F.

J Ocul Pharmacol Ther. 2006 Oct;22(5):370-6.PMID: 17076632 [PubMed - indexed for MEDLINE]Related articles

Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.

Jonas JB, Akkoyun I, Budde WM, Kreissig I, Degenring RF.

Arch Ophthalmol. 2004 Feb;122(2):218-22.PMID: 14769599 [PubMed - indexed for MEDLINE]Related articles

Intravitreal triamcinolone acetonide for exudative age related macular degeneration.

Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R.

Br J Ophthalmol. 2003 Apr;87(4):462-8.PMID: 12642311 [PubMed - indexed for MEDLINE]Related articlesFree article

Visual acuity change after intravitreal bevacizumab for exudative age-related macular degeneration in relation to subfoveal membrane type.

Jonas JB, Libondi T, Ihloff AK, Harder B, Kreissig I, Schlichtenbrede F, Sauder G, Spandau UH.

Acta Ophthalmol Scand. 2007 Aug;85(5):563-5. Epub 2007 Feb 27.PMID: 17324219 [PubMed - indexed for MEDLINE]Related articles

Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study.

Jonas JB, Akkoyun I, Kreissig I, Degenring RF.

Br J Ophthalmol. 2005 Mar;89(3):321-6.PMID: 15722313 [PubMed - indexed for MEDLINE]Related articlesFree article

Repeated intravitreal injection of triamcinolone for exudative age-related macular degeneration.

Jonas JB, Spandau UH, Kamppeter BA, Vossmerbaeumer U, Harder B.

Ophthalmic Res. 2006;38(6):324-8. Epub 2006 Oct 13.PMID: 17047404 [PubMed - indexed for MEDLINE]Related articles

Duration of the effect of intravitreal triamcinolone acetonide in eyes with exudative age-related macular degeneration.

Jonas JB, Spandau UH, Kamppeter BA, Degenring RF, Kreissig I, Akkoyun I, Vossmerbaeumer U.

J Ocul Pharmacol Ther. 2006 Jun;22(3):194-9.PMID: 16808681 [PubMed - indexed for MEDLINE]Related articles

Cataract surgery combined with intravitreal injection of triamcinolone acetonide.

Jonas JB, Kreissig I, Budde WM, Degenring RF.

Eur J Ophthalmol. 2005 May-Jun;15(3):329-35.PMID: 15945000 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab versus triamcinolone acetonide for exudative age-related macular degeneration.

Jonas JB, Ihloff AK, Harder B, Kreissig I, Schlichtenbrede F, Libondi T, Spandau UH, Vossmerbaeumer U.

Ophthalmic Res. 2009;41(1):21-7. Epub 2008 Oct 13.PMID: 18849638 [PubMed - indexed for MEDLINE]Related articles

Intravitreal triamcinolone acetonide for serous retinal pigment epithelial detachments in exudative age-related macular degeneration.

Sutter FK, Kurz-Levin MM, Scherrer M, Barthelmes D, Fleischhauer JC, Helbig H.

Klin Monbl Augenheilkd. 2007 Apr;224(4):297-9.PMID: 17458796 [PubMed - indexed for MEDLINE]Related articles

Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration.

Jonas JB, Spandau UH, Kamppeter BA, Harder B.

Eye (Lond). 2007 Mar;21(3):387-94. Epub 2006 Jan 13.PMID: 16410809 [PubMed - indexed for MEDLINE]Related articles

Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study.

Jonas JB, Degenring RF, Kreissig I, Friedemann T, Akkoyun I.

Eye (Lond). 2005 Feb;19(2):163-70.PMID: 15218517 [PubMed - indexed for MEDLINE]Related articles

Visual acuity and contrast sensitivity outcomes in Indian eyes undergoing photodynamic therapy with intravitreal injection of triamcinolone acetonide in age-related macular degeneration.

Kumar A, Sinha S, Kumar V.

Indian J Ophthalmol. 2007 May-Jun;55(3):207-11.PMID: 17456939 [PubMed - indexed for MEDLINE]Related articlesFree article

Intraocular pressure after intravitreal injection of triamcinolone acetonide.

Jonas JB, Kreissig I, Degenring R.

Br J Ophthalmol. 2003 Jan;87(1):24-7.PMID: 12488256 [PubMed - indexed for MEDLINE]Related articlesFree article

[Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization with pigment epithelium detachment in age-related macular degeneration]

Leparmentier A, Arnaud C, Fournie P, Mathis A, Quintyn JC.

J Fr Ophtalmol. 2007 Feb;30(2):155-60. French. Erratum in: J Fr Ophtalmol. 2007 Mar;30(3):231. Audrey, L [corrected to Leparmentier, A]. PMID: 17318098 [PubMed - indexed for MEDLINE]Related articlesFree article

Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.

Lee J, Freeman WR, Azen SP, Chung EJ, Koh HJ.

Retina. 2007 Nov-Dec;27(9):1205-13.PMID: 18046226 [PubMed - indexed for MEDLINE]Related articles

Predictive factors for visual acuity after intravitreal triamcinolone treatment for diabetic macular edema.

Jonas JB, Martus P, Degenring RF, Kreissig I, Akkoyun I.

Arch Ophthalmol. 2005 Oct;123(10):1338-43.PMID: 16219724 [PubMed - indexed for MEDLINE]Related articles

Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 1-year outcome.

Ruiz-Moreno JM, Montero JA, Barile S, Zarbin MA.

Retina. 2006 Jul-Aug;26(6):602-12.PMID: 16829800 [PubMed - indexed for MEDLINE]Related articles